SCHEMBL21752956

SCHEMBL21752956

O=C(c1ccc(Oc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)nc1)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
RAB9A P51151 1/20 0.45
LMNA P02545 2/20 0.42
HIF1A Q16665 7/20 0.40
LIPE Q05469 5/20 0.40
HRH3 Q9Y5N1 1/20 0.40
EPAS1 Q99814 2/20 0.39
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
BCHE P06276 1/20 0.39
HPGDS O60760 1/20 0.38
MDH1 P40925 1/20 0.38
MDH2 P40926 1/20 0.38
EP300 Q09472 1/20 0.38
CASP2 P42575 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628491 0.86 HIF1A (0.49) MEN1KMT2ARAB9ALMNAHIF1A
SCHEMBL21752960 0.85 MEN1 (0.50) MEN1KMT2ARAB9ALMNAHIF1A
SCHEMBL20827018 0.85 MEN1 (0.54) MEN1KMT2ARAB9ALMNAHIF1A
SCHEMBL21628411 0.83 HDAC6 (0.47) MEN1KMT2ARAB9AHIF1AEPAS1
SCHEMBL20482054 0.83 HIF1A (0.54) MEN1KMT2ARAB9ALMNAHIF1A
SCHEMBL21628483 0.82 MEN1 (0.45) MEN1KMT2ARAB9ALMNAHIF1A
SCHEMBL21628643 0.82 OPRM1 (0.49) MEN1KMT2ARAB9ALMNAHIF1A
SCHEMBL21656984 0.80 PDE4B (0.53) MEN1KMT2ARAB9ALMNAHIF1A
SCHEMBL19638786 0.75 ALDH1A1 (0.57) MEN1KMT2ARAB9ALMNAHIF1A
SCHEMBL31225326 0.75 ALDH1A1 (0.57) MEN1KMT2ARAB9ALMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250368595-A1 NOVEL MOLECULES Xeniopro GmbH (DE) 2025-12-04 US disclosed
US-20230141913-A2 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY Xeniopro GmbH (DE) 2023-05-11 US disclosed
US-20220249500-A1 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY Xeniopro GmbH (DE) 2022-08-11 US disclosed
EP-3841091-A1 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERATIVE ACTIVITY Xeniopro GmbH (DE) 2021-06-30 EP disclosed
CN-112930337-A Antiproliferative phenoxy (hetero) aryl ethers 赛尼欧普罗有限责任公司 2021-06-08 CN disclosed
WO-2020039094-A1 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERATIVE ACTIVITY Xeniopro GmbH (DE) 2020-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220249500-A1 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY AHR, MUSK, TYR MEN1 4794/4885KMT2A 762/4885RAB9A 2351/4885
US-20250368595-A1 NOVEL MOLECULES MUSK, IKZF3, TYR MEN1 4589/4885KMT2A 957/4885RAB9A 2783/4885
US-20230141913-A2 PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY AHR, MUSK, TYR MEN1 4794/4885KMT2A 762/4885RAB9A 2351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.